NGS Oncology Assays

Overview

The AVENIO family of next-generation sequencing (NGS) oncology assays comprises three liquid biopsy assays and three new corresponding tissue assays with matched panel content. New AVENIO Tumor Tissue Analysis Kits, together with AVENIO ctDNA Analysis Kits, offer a uniquely versatile solution for comprehensive genomic profiling, longitudinal monitoring and concordance analysis of solid tumors from tissue and plasma samples.

Overview

The AVENIO family of next-generation sequencing (NGS) oncology assays comprises three liquid biopsy assays and three new corresponding tissue assays with matched panel content. New AVENIO Tumor Tissue Analysis Kits, together with AVENIO ctDNA Analysis Kits, offer a uniquely versatile solution for comprehensive genomic profiling, longitudinal monitoring and concordance analysis of solid tumors from tissue and plasma samples.

Features and Benefits of AVENIO NGS Oncology Assays

Flexibility to switch between tissue and plasma to support a variety of research applications
Exactly-matched tissue and ctDNA panels (same genes, gene regions and hybrid-capture workflow) for true concordance
All four mutation classes (SNVs, indels, fusions and CNVs) in a single DNA workflow with exceptional sensitivity and specificity*
A streamlined, end-to-end workflow from extraction to analysis and reporting in 5 days
Includes reagents for DNA extraction, library preparation and target enrichment, as well as bioinformatics and software required to analyze sequencing data and generate reports